Titration procedures for nasal CPAP: Automatic CPAP or prediction formula? by Hertegonne, Katrien et al.
ARTICLE IN PRESSwww.elsevier.com/locate/sleep
Sleep Medicine xxx (2007) xxx–xxxOriginal Article
Titration procedures for nasal CPAP: Automatic CPAP
or prediction formula? q
Katrien B. Hertegonne a,*, Jana Volna b, Soﬁe Portier c, Rebecca De Pauw a,
Georges Van Maele d, Dirk A. Pevernagie a
a Centre for Sleep Disorders, Department of Respiratory Diseases, Ghent University Hospital, De Pintelaan 185, 9000 Gent, Belgium
b Department of Neurology, Katerinska 30, Praha 2 12000, Czech Republic
c Ghent University, Belgium
d Department of Medical Statistics, University Hospital, De Pintelaan 185, 9000 Gent, Belgium
Received 29 January 2007; received in revised form 13 August 2007; accepted 13 August 2007Abstract
Background: The best method for titration of continuous positive airway pressure (CPAP) therapy in obstructive sleep apnea (OSA)
syndrome has not yet been established. The 90th or 95th percentiles of the pressure titrated over time by automatic CPAP (A-CPAP)
have been recommended as reference for prescribing therapeutic ﬁxed CPAP (F-CPAP). We compared A-CPAP to F-CPAP, which
was determined by a common prediction formula.
Methods: Forty-ﬁve patients who were habituated to F-CPAP underwent titration polysomnography. In a double-blind, random-
ized order, each patient used an A-CPAP device in the autotitration and in the ﬁxed pressure mode during one half of the night.
Apnea–hypopnea index (AHI) and pressure proﬁles were primary outcomes. Bias and precision were additionally assessed for both
CPAP modes.
Results: No signiﬁcant diﬀerences in various sleep parameters or in subjective sleep quality evaluation were found. The AHI was
eﬀectively lowered in both CPAP modes (A-CPAP 7.7 [10.8] events/h versus F-CPAP 5.4 [9.0] events/h, p = 0.061). Comparison
of group means showed that F-CPAP closely paralleled mean (Pmean) and median (P50), but not the 95th percentile (P95) pressure,
of A-CPAP. While bias was lowest for Pmean and P50, there was a lack of precision in all A-CPAP pressure categories.
Conclusions: We conﬁrm that F-CPAP set by prediction formula is not worse in terms of AHI control than A-CPAP. On average,
F-CPAP parallels Pmean and P50 but not P95. However, due to imprecise matching, individual F-CPAP values cannot be derived
from Pmean or P50.
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More than two decades after nasal continuous posi-
tive airway pressure (CPAP) has become available as a
treatment option for obstructive sleep apnea (OSA),
the best procedure to determine optimal pressure levels
for long-term CPAP therapy remains controversial.
While manual CPAP titration has been recommended
as a standard operating procedure for this purpose [1],
clear directives on how to carry out manual titrationprocedures for nasal CPAP: Automatic CPAP ..., Sleep Med
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titration algorithms that are suitable to treat all patients
are still lacking.
In recent years, automatic CPAP (A-CPAP) devices
have been developed aiming at safe and eﬃcient pressure
adaptation to meet the patient’s variable pressure needs
[2,3]. A-CPAP can be used for permanent home treat-
ment or to titrate a level of pressure that is suitable
for long-term treatment with ﬁxed CPAP (F-CPAP).
In previous reports, evidence was provided indicating
that an A-CPAP titration procedure is as eﬃcient as
manual titration in assuring respiratory control [4],
and that the 90th [5,6] or 95th percentiles [7–10] of the
pressure titrated by A-CPAP have been suggested as ref-
erence pressure levels for F-CPAP treatment at home.
Other research has focused on the prediction of eﬀec-
tive CPAP using formulas that include respiratory and/
or anthropometric parameters [10,11]. Prediction for-
mulas were found to be useful in simplifying manual
CPAP titration [12,13] or even equally eﬃcient as stan-
dard titration in ﬁnding the required F-CPAP [14,15].
Hukins et al. demonstrated that ‘arbitrary’ CPAP based
on body mass index (BMI) resulted in clinical improve-
ment similar to CPAP determined by manual titration
[16]. Another large prospective multi-center trial com-
pared the eﬀects of a prediction formula, A-CPAP and
manual titration, and found that these three methods
were equally eﬀective in improving subjective sleepiness
and the apnea–hypopnea index (AHI) [6]. This was con-
ﬁrmed in a prospective study performed at home, where
diﬀerent methods of CPAP assessment resulted in com-
parable clinical outcomes [17]. However, despite increas-
ing evidence that alternative methods for assessment of
CPAP are eﬀective, manual titration still prevails in oﬃ-
cial guidelines, although it is the most labour-intensive
and expensive procedure.
The goal of the present study was to evaluate whether
A-CPAP is superior to ‘empirical’ CPAP determined by
a prediction formula for the assessment of optimal air-
way pressure. The primary outcome measure of this
investigation was the AHI; secondary outcome measures
were pressure proﬁles and subjective appraisal of sleep
quality.
2. Materials and methods
2.1. Study subjects
From May 2005 to December 2005, 62 patients with
an AHI > 20/h plus an arousal index > 30/h (i.e., Bel-
gian criteria for reimbursement of nasal CPAP) were
considered for participation. Exclusion criteria were a
history of prior uvulopalatopharyngoplasty (UPPP),
signs of severe nasal obstruction, excessive sleep disrup-
tion due to non-respiratory causes, chronic obstructive
pulmonary disease (COPD; i.e., forced expiratory vol-Please cite this article in press as: Hertegonne KB et al., Titration
(2007), doi:10.1016/j.sleep.2007.08.009ume in 1 s [FEV1]/forced vital capacity [FVC] < 65%),
inadequate CPAP compliance at home (average use
<3 h per night), central sleep apnea and congestive heart
failure. After screening, 10 subjects were excluded
because of poor CPAP compliance and another one
because of central sleep apnea. After inclusion, six more
patients were excluded because of technical problems
(i.e., critical loss of data in one or more polysomno-
graphic channels). Finally, 45 patients successfully com-
pleted the study. The trial was approved by the Ethical
Review Board of our institution and all participants
gave written informed consent.
2.2. Sleep studies
Polysomnography was carried out using a 19-chan-
nel digital polygraph (Morpheus, Medatec, Brussels,
Belgium). During baseline studies, nasal pressure can-
nulae were used to record airﬂow; the prongs were con-
nected via ﬂexible tubing 4 mm in diameter to the
built-in manometer (Honeywell 164PC01D37, Free-
port, IL, USA). The signal was sampled at 200 Hz with
appropriate ﬁlter settings (TC = 10 s, LP = 20 Hz) and
in order to correct for non-linearity the square-root
was performed on this pressure signal [18]. During
the A-CPAP trial, airﬂow was evaluated by measuring
the respiratory pressure ﬂuctuations in the nasal mask
using the same method as described above. This
recording closely resembles the signal derived from
nasal cannulae and allows reliable detection of apneas,
hypopneas and ﬂow-limitation. Respiratory movements
were recorded using thoracic and abdominal piezo-sen-
sors (Sleepmate, Midlothian, VA, USA). Respiratory
events were manually scored according to contempo-
rary guidelines [19]. Brieﬂy, an apnea was deﬁned as
a total cessation of airﬂow during at least 10 s; a hypo-
pnea was deﬁned as a decrease in airﬂow of at least
50% or a clear decrease of less than 50% with an oxy-
gen desaturation >3% and/or an arousal. The AHI was
calculated as the sum of apneas and hypopneas divided
by total sleep time (h). Inspiratory snores were manu-
ally counted and the snoring index was computed as
the sum of inspiratory snores divided by total sleep
time (h). Sleep stages were identiﬁed according to stan-
dard criteria [20], arousals were scored based on pub-
lished guidelines [21] and the arousal index was the
sum of arousals divided by total sleep time (h). Sleep
stages, respiratory and snoring events and arousals
were assessed by polysomnography in epochs of 30 s,
and CPAP levels were determined as the average pres-
sure level over the 30-s epoch.
2.3. Study design
After the diagnosis of OSA was established, patients
were habituated on CPAP treatment at home. The pres-procedures for nasal CPAP: Automatic CPAP ..., Sleep Med
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and is referred to as ‘F-CPAP’ in the results and discus-
sion session. During follow-up consultation after
1 month, it was evaluated whether adjustment was
needed based on residual symptoms of sleepiness or
snoring. With respect to snoring, the patients were asked
to obtain reliable information from bed-partners, rela-
tives, house-mates or occasional travelling companions.
None of the patients actually required pressure adapta-
tion. The mean habituation period prior to the titration
polysomnography was 89.1 (37.2) days, and the CPAP
compliance was 5.7 (1.5) h per night.
After the habituation period, an overnight polysom-
nography was carried out in the laboratory. In a dou-
ble-blind, randomized order, two identical REMstar
Auto devices (Murrysville, PA, USA) were used for
each patient during the same night: one in the automatic
titration mode and one in the ﬁxed mode. Four hours
after the start of polysomnography, the tubing was dis-
connected from the ﬁrst device and attached to the sec-
ond, which was then used for another 4 h. In the auto-
titration mode, the pressure was programmed to a range
between 4 and 14 cm H2O, whereas in the ﬁxed mode
the pressure was set at the predicted level. Both methods
were compared regarding their eﬀect on relevant sleep
and respiratory variables. In A-CPAP mode, the mean
(Pmean), median (P50), maximum (Pmax), 90th (P90)
and 95th percentile (P95) of the airway pressure values
were computed from the polysomnography data. Statis-
tics on air leakage were obtained from the internal
memory of the CPAP devices. Scoring was performed
by one skilled technician and reviewed by the ﬁrst
author, both of whom were blinded to treatment
conditions.
The morning after the titration study a subjective
evaluation of sleep quality was carried out, using a
questionnaire and visual analogue scales ranging
between 0 (best score) and 10 (worst score). Four ques-
tions were asked: (Q1) Did the pressure changes dis-
turb my falling asleep?; (Q2) Did the pressure
changes cause awakenings?; (Q3) How did the CPAP
device aﬀect my sleep quality?; (Q4) Did the noise of
the device disturb my sleep? The questions were dupli-
cated for both halves of the night. In addition, the
patients were asked to indicate their preference for
one of the devices as if they would have to choose
between them for continued use at home. All patients
responded aﬃrmatively to the question asked by the
technician about whether they had good recall of the
treatment eﬀects in the ﬁrst versus the second half of
the night. This subjective preference was compared
with objective preference, which was deﬁned in terms
of better AHI control: when a (arbitrarily chosen) dif-
ference of >3 events/h was found, the device with the
lowest AHI was considered preferable; a diﬀerence
63 was considered equivocal.Please cite this article in press as: Hertegonne KB et al., Titration
(2007), doi:10.1016/j.sleep.2007.08.0092.4. Power calculation and statistical analysis
The estimated number of required subjects was 45,
based on the following assumptions: a diﬀerence in
AHI of 3 or more events/h, standard deviation equal
to 5 events/h, statistical power of 0.8 and a two-tailed
signiﬁcance level of 0.05. Analysis of variance
(ANOVA) was carried out to assess a potential eﬀect
of treatment order (ﬁrst versus second half of the night)
on the AHI and Mann–Whitney U-test on the pressure
outcomes. The Wilcoxon signed rank test for matched
pairs was applied to assess diﬀerences between treatment
conditions. Bias, precision and maximum errors were
calculated for the diﬀerences between F-CPAP and the
various levels of A-CPAP; bias was deﬁned as the mean
and precision as the standard deviation of the individu-
ally subtracted values. The McNemar test was used to
compare subjective and objective outcomes. SPSS ver-
sion 12.0 software was used.
3. Results
Forty-ﬁve patients (36 males and 9 females) success-
fully completed the study (mean [standard deviation]
age 52.4 [10.9] years, BMI 31.1 [7.3] kg/m2, FEV1/
FVC 78.0 [4.8]%, AHI 45.8 [25.0] events/h, arousal
index 51.0 [20.2] events/h).
Comparison of the two CPAP methods showed no
signiﬁcant diﬀerences in various sleep parameters,
including time in bed, total sleep time, sleep eﬃciency,
sleep stages and arousal index (Table 1).
As a result of the randomization procedure, 25
patients were started on F-CPAP versus 20 on A-CPAP
in the ﬁrst half of the night. ANOVA did not reveal a
signiﬁcant eﬀect of treatment order on AHI
(p = 0.125). Comparison of pressure proﬁles in subjects
receiving A-CPAP in the ﬁrst versus the second half of
the night did not show signiﬁcant diﬀerences.
Data on respiratory events and snoring are presented
in Table 2. The residual AHI was not signiﬁcantly diﬀer-
ent in both treatment conditions; only the central apnea
index was signiﬁcantly higher in A-CPAP than in F-
CPAP mode.
The residual AHI wasP10 events/h in six subjects on
F-CPAP compared to 10 on A-CPAP, and was <10 but
P5 events/h in 11 subjects on F-CPAP compared to
seven on A-CPAP. Twenty-eight individuals in each
treatment condition had an AHI < 5 events/h.
F-CPAP (7.5 [1.6] cm H2O) was compared with dif-
ferent A-CPAP statistics: Pmean was 7.5 [2.2] cm H2O
(p = 0.973); P50 was 7.6 [2.7] cm H2O (p = 0.946); P90
was 9.8 [2.5] cm H2O (p < 0.001); P95 was 10.1
[2.4] cm H2O (p < 0.001); Pmax was 10.8 [2.3] cm H2O
(p < 0.001) (Fig. 1).
Data on leaks showed no diﬀerences (mean leak F-
CPAP 30.9 [7.7] versus A-CPAP 30.9 [9.3]).procedures for nasal CPAP: Automatic CPAP ..., Sleep Med
Table 1
Sleep parameters in both treatment conditions
A-CPAP F-CPAP Signiﬁcance
Time in bed, min 233.6 (22.2) 233.1 (21.6) p = 0.448
Total sleep time, min 176.6 (37.4) 172.9 (38.5) p = 0.550
Sleep eﬃciency, % 75.6 (14.5) 73.9 (15.2) p = 0.611
Wakefulness, min 57.1 (34.8) 60.2 (31.8) p = 0.498
NREM stage 1, min 15.2 (7.0) 14.2 (8.1) p = 0.296
NREM stage 1, % TST 9.4 (5.6) 8.8 (5.6) p = 0.541
NREM stage 2, min 95.5 (27.2 95.3 (30.4) p = 0.919
NREM stage 2, % TST 55.2 (14.0) 53.9 (14.2) p = 0.795
NREM stage 3–4, min 31.9 (28.5) 24.6 (22.9) p = 0.188
NREM stage 3–4, % TST 16.9 (14.9) 14.8 (13.8) p = 0.453
REM sleep, min 33.9 (20.4) 38.8 (27.5) p = 0.561
REM sleep, % TST 18.7 (10.3) 22.5 (14.9) p = 0.218
Arousal index, #/h 32.8 (19.9) 29.7 (18.8) p = 0.183
Table 2
Residual apnea, hypopnea and snoring indexes in both treatment
conditions
A-CPAP F-CPAP Signiﬁcance
Apnea–hypopnea index, #/h 7.7 (10.8) 5.4 (9.0) p = 0.061
Central apnea index, #/h 2.1 (4.8) 0.8 (2.0) p = 0.031
Obstructive apnea index, #/h 0.6 (1.7) 0.6 (1.5) p = 0.715
Hypopnea index, #/h 5.0 (7.3) 3.9 (6.4) p = 0.248
Snoring index, #/h 13.6 (33.5) 15.3 (53.2) p = 0.350
Fig. 1. Pressure proﬁles. The horizontal black line is median, the box
interquartile range and vertical line the min–max range. F-CPAP: 7.5
[1.6] cm H2O. A-CPAP: Pmean: 7.5 [2.2] cm H2O (p = 0.973 versus F-
CPAP); P50: 7.6 [2.7] cm H2O (p = 0.946 versus F-CPAP); P90: 9.8
[2.5] cm H2O (p < 0.001 versus F-CPAP); P95: 10.1 [2.4] cm H2O
(p < 0.001 versus F-CPAP); Pmax: 10.8 [2.3] cm H2O (p < 0.001 versus
F-CPAP).
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(2007), doi:10.1016/j.sleep.2007.08.009Table 3 shows the bias, precision and maximum
errors for inter-individual diﬀerences between F-CPAP
and various A-CPAP statistical categories. Pmean and
P50 had the least bias compared with F-CPAP, whereas
bias increased progressively over P90, P95 and Pmax.
All categories of A-CPAP demonstrated considerable
imprecision with respect to F-CPAP.
Results of the subjective evaluation are presented in
Fig. 2, comprising data of four visual analogue scales.
No signiﬁcant diﬀerences in subjective comfort measures
were found. Remarkably, as the data in Table 4 illus-
trate, the disparity between subjective and objective
assessments was signiﬁcant.Table 3
Diﬀerence between F-CPAP and A-CPAP
Diﬀerences, cm H2O
(F-CPAP  A-CPAP)
Pmean P50 P90 P95 Pmax
Mean (bias) 0.02 0.05 2.29 2.58 3.30
SD (precision) 2.22 2.61 2.51 2.44 2.35
Minimum 5.17 6.54 6.81 6.84 7.32
Maximum 4.53 4.76 3.19 2.95 2.00
Diﬀerences between F-CPAP and A-CPAP presented in terms of bias
and precision, where bias is the mean and precision is the standard
deviation of the individually subtracted values. In addition, the largest
errors, either positive or negative, are shown.
Fig. 2. Sleep quality (VAS). The horizontal black line is median, the
box interquartile range and vertical line the min–max range. Comfort
of CPAP use in A-CPAP and F-CPAP mode. The questions were
duplicated for the ﬁrst and second half of the night. (Q1) Did the
pressure changes disturb my falling asleep? (Q2) Did the pressure
changes cause awakenings? (Q3) How did the CPAP device aﬀect my
sleep quality? (Q4) Did the noise of the device disturb my sleep? Range
of the visual analogue scale (VAS): 0 = best score; 10 = worst score.
No statistically signiﬁcant diﬀerences were found.
procedures for nasal CPAP: Automatic CPAP ..., Sleep Med
Table 4
Subjective versus objective preferences
Subjective preference (%) Objective preference (%)
A-CPAP 36 7
F-CPAP 33 31
Indiﬀerent 31 62
McNemar test: p = 0.013.
Subjective preference was indicated by the patients in the post-sleep
questionnaire (see Section 2).
Objective preference was derived from the AHI control. If the diﬀer-
ence in AHI between the two treatment conditions was >3 events/h,
the device corresponding with the lowest AHI was preferred. If the
diﬀerence was 63 events/h, none of either was preferred.
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We report the results of a double-blind, randomized
comparative cross-over trial in which predicted F-CPAP
was matched against A-CPAP in a CPAP titration set-
ting. While the residual AHI was not signiﬁcantly diﬀer-
ent in either CPAP mode, higher pressure in A-CPAP
mode was observed. In terms of bias, F-CPAP corre-
sponded best with Pmean and P50 of A-CPAP, suggest-
ing that the use of P90 or P95 as the ﬁxed pressure for
chronic treatment could result in over-prescription.
However, in terms of precision, the equivalence between
F-CPAP and A-CPAP was poor. There was no diﬀer-
ence in subjective appreciation of the two CPAP modes,
and there was no correspondence between subjective
and objective ratings.
No diﬀerences were found between the two treat-
ment arms regarding various sleep variables, including
total sleep time, sleep eﬃciency, sleep stages and arou-
sal index. This ﬁnding illustrates that randomization
was eﬀective and that both treatment options are asso-
ciated with similar eﬀects on sleep quality. The split-
night approach might be considered a limitation of this
study, as the individual CPAP exposure is restricted to
a period of 4 h in each treatment mode. There are no
available data directly comparing half-night with all-
night A-CPAP titrations. Factors that aﬀect pressure
in A-CPAP mode such as arousals and changes of
sleep stage may be diﬀerent in full versus partial-night
studies. However, split-night titration is accepted as a
feasible alternative for full-night CPAP titration in cer-
tain patients during diagnostic sleep studies [22,23].
Moreover, splitting the night in two halves allows a
cross-over design, which adds to the power of the
study. At variance with conventional split-night proto-
cols is the fact that in the present trial patients were
habituated on F-CPAP for more than 2 months before
entering the titration procedure. The lag between the
diagnostic and titration sleep study is not unfavourable
by itself because sleep architecture may be closer to
normal because of the intercurrent habituation to
CPAP. Prior acclimatization to CPAP will probablyPlease cite this article in press as: Hertegonne KB et al., Titration
(2007), doi:10.1016/j.sleep.2007.08.009reduce or eliminate the rebound of slow wave and
rapid eye movement (REM) sleep, which is often seen
as a ﬁrst-night eﬀect in acute CPAP treatment condi-
tions [24]. Furthermore, it has been shown that sleep
eﬃciency during CPAP titration is signiﬁcantly higher
in subjects who are habituated on CPAP than in
CPAP-naive patients [16]. Taking into account these
considerations, we believe that the design of the present
study was appropriate for the comparative evaluation
of both CPAP modes.
Of particular interest is the observation that all
included patients tolerated F-CPAP well. The pressure
level was calculated according to the prediction formula
of Miljeteig et al. [11]. We elected this method over other
pressure estimation models because it has been used for
the determination of reference pressure by diﬀerent
investigators [6,12,25]. F-CPAP seemed adequate for
symptomatic control, as all patients reported satisfac-
tory improvement of subjective sleepiness and snoring.
Therefore, no pressure adjustments had to be made dur-
ing follow-up visits. Moreover, this pressure level
proved suﬃcient for reducing AHI to less than
10 events/h in 39/45 subjects, which is a criterion for
an acceptable treatment result [26]. A-CPAP did not
improve this outcome any further; in only 35/45 subjects
was the same criterion fulﬁlled. Starting F-CPAP based
on either predicted or arbitrary pressure has likewise
been found to be a feasible treatment modality in three
recent clinical trials [6,16,17]. In the most recent study
by West et al., 98 patients were randomized into three
groups: A-CPAP throughout, F-CPAP based on P95
and F-CPAP based on prediction formula [17]. While
there was no signiﬁcant diﬀerence in any of the clinical
outcome measures after 6 months, the P95 subgroup
received higher pressures than the predicted pressure
or A-CPAP cohorts. The authors suggested that admin-
istration of lower pressure is equally eﬀective to improve
AHI and reduce symptoms. This ﬁnding is in keeping
with the results of the present study.
Using the 90th or 95th percentile of an A-CPAP pres-
sure range is still regarded by many as an appropriate
and eﬃcient method to assess the level of F-CPAP for
long-term treatment [4,7,8]. Since patients seem to do
equally well with lower average pressure levels, the ques-
tion must be raised whether assessment of P95 really
yields the ‘optimal’ pressure. In a recent report, it was
pointed out that signiﬁcant diﬀerences in P95 exist
between diﬀerent brands of A-CPAP devices, with con-
siderable bias (3.0 cm H2O) and wide limits of agree-
ment (ranging from +9.3 to 3.2 cm H2O) [9]. In an
earlier study, insigniﬁcant changes in group means were
found when P95 was re-assessed with A-CPAP after 1
and 6 months of treatment [27]. However, large stan-
dard deviations were disclosed, which were indicative
of considerable individual variability in pressure
requirement, in positive or negative direction. Theprocedures for nasal CPAP: Automatic CPAP ..., Sleep Med
6 K.B. Hertegonne et al. / Sleep Medicine xxx (2007) xxx–xxx
ARTICLE IN PRESSresults of the present study cast further doubt on the
validity of the P95 for F-CPAP determination. Among
the diﬀerent A-CPAP statistical variables, we found that
F-CPAP levels corresponded best with Pmean and P50
but not with P90, P95 or Pmax. Using the P95 for set-
ting of F-CPAP in this group of patients would have
resulted in over-prescription of airway pressure by an
average of 2.58 cm H2O. Further studies are needed to
clarify the issue of the validity of P95 assessment for
subsequent F-CPAP treatment. The observed impreci-
sion of the P95 could reﬂect random variation in CPAP
requirements by the patients on the one hand, but also
intrinsic variability of the A-CPAP methodology on
the other hand.
A poor agreement between F-CPAP and Pmean or
the diﬀerent percentiles of A-CPAP was found in the
present study. The standard deviations of the diﬀerences
were large and ﬂuctuated around 2.50 cm H2O. Accord-
ingly, the correspondence between the individual F-
CPAP and A-CPAP values was not precise. For
instance, if Pmean would have been used to decide on
the level of ﬁxed CPAP, 40% of the individuals would
have been more than 2.22 cm H2O away from the value
determined by the prediction formula. Although the
group means for F-CPAP and Pmean were identical in
this study (7.5 cm H2O), substituting F-CPAP by Pmean
values would be at risk for substantial individual error
up to 5.17 cm H2O in the negative and 4.53 cm H2O in
the positive direction. From the present data, Pmean
or P50 values cannot be recommended for setting the
level of ﬁxed pressure in the context of permanent CPAP
usage at home. The same applies to P90, P95 and Pmax
values which, in addition, have considerable bias regard-
ing F-CPAP. The lack of precision observed in the pres-
ent investigation is in agreement with results from other
clinical trials [10,27]. The data from our current study
seem to support the conclusion of these studies that
there probably is a range of CPAP over which adequate
control of OSA and associated symptoms can be main-
tained. In this respect, predicted pressure might have
similar accuracy and clinical outcome to pressure
derived from A-CPAP titration.
In conclusion, it was demonstrated in the current
study that F-CPAP and A-CPAP resulted in similar
control of the AHI but with higher pressure in A-CPAP
mode. The patients showed no subjective preference for
one of both treatment modes. In terms of bias, F-CPAP
corresponded best with Pmean and P50, not with P90,
P95 and Pmax of the pressure titrated over time by A-
CPAP. However, there was a considerable lack of agree-
ment between the two CPAP modes. This would pre-
clude extrapolation of individual A-CPAP titration
data to predicted pressure values. Finally, it seems that
there is no additional advantage in performing an A-
CPAP titration procedure if patients are stable under
predicted F-CPAP.Please cite this article in press as: Hertegonne KB et al., Titration
(2007), doi:10.1016/j.sleep.2007.08.009Acknowledgements
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